Editorial & Columns AI-focused Partnerships of Global Pharmaceutical Companies December 5, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Cultivating Intrapreneurship: Lessons from Leading Pharmaceutical Companies November 21, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Monitoring Prices, Availability, Accessibility & Affordability of Medicines-Role of PMRUs November 14, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Pharmapreneurs in India and their Career Transition November 6, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns FY24 Review: Intellectual Capital of Top Indian Pharmaceutical Companies October 28, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Employment Dynamics in Indian Pharmaceutical Industry October 16, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Sustainable Finance in India: Gaining Traction October 9, 2024 | Dr. Anil Kumar Angrish | No Comments | More